Van Hoose Kyri K. 4
4 · Dermata Therapeutics, Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Van Hoose Kyri K.
SVP, CFO
Transactions
- Award
Stock Option (right to buy)
2025-01-13+20,000→ 20,000 totalExercise: $1.38Exp: 2035-01-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1](1) The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.